1252.2000 31.90 (2.61%)
NSE Aug 13, 2025 13:01 PM
Volume: 480.8K
 

1252.20
2.61%
Karvy
US business declines, margins outperform: DRL's revenues increased by 7% YoY to Rs 37.9 bn (lower than our estimates of Rs 38.9 bn) primarily due to de-growth in US business on account of higher pricing pressure due to incremental competition in some of the key products.
Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
More from Dr. Reddy's Laboratories Ltd.
Recommended